KR101272093B1 - 린테우스 상황버섯이 함유된 식용 달팽이 사료 및 그 사료를 이용한 식용 달팽이 사육방법 - Google Patents
린테우스 상황버섯이 함유된 식용 달팽이 사료 및 그 사료를 이용한 식용 달팽이 사육방법 Download PDFInfo
- Publication number
- KR101272093B1 KR101272093B1 KR1020120101463A KR20120101463A KR101272093B1 KR 101272093 B1 KR101272093 B1 KR 101272093B1 KR 1020120101463 A KR1020120101463 A KR 1020120101463A KR 20120101463 A KR20120101463 A KR 20120101463A KR 101272093 B1 KR101272093 B1 KR 101272093B1
- Authority
- KR
- South Korea
- Prior art keywords
- feed
- edible
- linteus
- snail
- edible snail
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000237369 Helix pomatia Species 0.000 title claims abstract description 63
- 241000001727 Tropicoporus linteus Species 0.000 title abstract description 6
- 238000000034 method Methods 0.000 title description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 59
- 238000009395 breeding Methods 0.000 claims abstract description 24
- 230000001488 breeding effect Effects 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 15
- 229910052791 calcium Inorganic materials 0.000 claims description 15
- 241000209094 Oryza Species 0.000 claims description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims description 12
- 235000009566 rice Nutrition 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- 235000013527 bean curd Nutrition 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 241000282887 Suidae Species 0.000 claims 2
- 238000012364 cultivation method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 238000001784 detoxification Methods 0.000 abstract description 12
- 230000002708 enhancing effect Effects 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 235000004213 low-fat Nutrition 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 25
- 201000011510 cancer Diseases 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 13
- 230000001093 anti-cancer Effects 0.000 description 9
- 150000004676 glycans Chemical class 0.000 description 8
- 230000036737 immune function Effects 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 6
- 229920002498 Beta-glucan Polymers 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000002865 immune cell Anatomy 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229920002567 Chondroitin Polymers 0.000 description 3
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000237858 Gastropoda Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 244000305267 Quercus macrolepis Species 0.000 description 2
- 235000016976 Quercus macrolepis Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 240000006794 Volvariella volvacea Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000422 nocturnal effect Effects 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000123107 Phellinus Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 241000789545 Trimeria grandifolia Species 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002907 effect on anemia Effects 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000025189 neoplasm of testis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 201000004338 pollen allergy Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012629 purifying agent Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims (3)
- 미강 25~30㎏, 콩비지 12~18㎏, 칼슘제 15~25㎏, 육성돈 후기 사료 20~30㎏, 린테우스 상황버섯 가루 2~5㎏를 혼합한 다음 물을 첨가 반죽하여 50~80%의 함수율을 가진 린테우스 상황버섯이 함유된 식용 달팽이 사료.
- 미강 25~30㎏, 콩비지 12~18㎏, 칼슘제 15~25㎏, 육성돈 후기 사료 20~30㎏, 린테우스 상황버섯 가루 2~5㎏를 혼합한 다음 물을 첨가 반죽하여 50~80%의 함수율을 가진 린테우스 상황버섯이 함유된 사료를 얻고,
상기 사료를 이용하여 식용 달팽이를 사육하도록 함을 특징으로 하는 린테우스 상황버섯이 함유된 식용 달팽이 사료를 이용한 식용 달팽이 사육방법. - 새끼 식용 달팽이에게 몸집 크기 2배 부피의 사료를 1주일에 2~3번 주면서 2개월 사육하고, 이어 성충 사육조로 분가시켜 같은 사료를 1주일에 2~3번 주면서 3개월 사육 후 출하하되,
상기 사료는, 미강 25~30㎏, 콩비지 12~18㎏, 칼슘제 15~25㎏, 육성돈 후기 사료 20~30㎏, 린테우스 상황버섯 가루 2~5㎏를 혼합한 다음 물을 첨가 반죽하여 50~80%의 함수율을 가진 사료임을 특징으로 하는 린테우스 상황버섯이 함유된 식용 달팽이 사료를 이용한 식용 달팽이 사육방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120101463A KR101272093B1 (ko) | 2012-09-13 | 2012-09-13 | 린테우스 상황버섯이 함유된 식용 달팽이 사료 및 그 사료를 이용한 식용 달팽이 사육방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120101463A KR101272093B1 (ko) | 2012-09-13 | 2012-09-13 | 린테우스 상황버섯이 함유된 식용 달팽이 사료 및 그 사료를 이용한 식용 달팽이 사육방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101272093B1 true KR101272093B1 (ko) | 2013-06-07 |
Family
ID=48866398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120101463A Expired - Fee Related KR101272093B1 (ko) | 2012-09-13 | 2012-09-13 | 린테우스 상황버섯이 함유된 식용 달팽이 사료 및 그 사료를 이용한 식용 달팽이 사육방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101272093B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104256108A (zh) * | 2014-07-01 | 2015-01-07 | 张久兵 | 一种乳猪营养饲料及其制作方法 |
KR101843105B1 (ko) * | 2017-03-09 | 2018-03-28 | 정병권 | 양파껍질을 이용한 애벌레용 사육 매트 및 그의 제조방법 |
KR101923694B1 (ko) | 2017-02-15 | 2018-11-29 | 주식회사 코씨드바이오팜 | 홍삼과 병풀을 함유하는 달팽이 사료 및 달팽이 사육방법 |
KR102605534B1 (ko) | 2022-08-03 | 2023-11-24 | 박헌의 | 산삼배양근 배양 배지를 이용한 식용 달팽이용 사료 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030044791A (ko) * | 2001-11-29 | 2003-06-09 | 앤씨 바이오텍 주식회사 | 버섯균사체를 이용한 가축 및 해수어, 담수어, 대하의기능성 사료 제조방법 및 첨가물질 |
KR100393255B1 (ko) | 2000-01-18 | 2003-07-31 | 임창택 | 콘드로이틴 황산의 함량을 증가시키는 달팽이용 사료 및이를 이용하여 양식한 달팽이 |
-
2012
- 2012-09-13 KR KR1020120101463A patent/KR101272093B1/ko not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100393255B1 (ko) | 2000-01-18 | 2003-07-31 | 임창택 | 콘드로이틴 황산의 함량을 증가시키는 달팽이용 사료 및이를 이용하여 양식한 달팽이 |
KR20030044791A (ko) * | 2001-11-29 | 2003-06-09 | 앤씨 바이오텍 주식회사 | 버섯균사체를 이용한 가축 및 해수어, 담수어, 대하의기능성 사료 제조방법 및 첨가물질 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104256108A (zh) * | 2014-07-01 | 2015-01-07 | 张久兵 | 一种乳猪营养饲料及其制作方法 |
KR101923694B1 (ko) | 2017-02-15 | 2018-11-29 | 주식회사 코씨드바이오팜 | 홍삼과 병풀을 함유하는 달팽이 사료 및 달팽이 사육방법 |
KR101843105B1 (ko) * | 2017-03-09 | 2018-03-28 | 정병권 | 양파껍질을 이용한 애벌레용 사육 매트 및 그의 제조방법 |
KR102605534B1 (ko) | 2022-08-03 | 2023-11-24 | 박헌의 | 산삼배양근 배양 배지를 이용한 식용 달팽이용 사료 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Habryka et al. | Bee products used in apitherapy | |
CN102940157B (zh) | 用于提高草鱼抗病能力的中药饲料添加剂 | |
CN107432397A (zh) | 一种人参小分子肽复配的固体饮料及其制备方法 | |
CN105595224A (zh) | 一种海参盐藻葡聚糖硒制剂及制备工艺 | |
CN102349608B (zh) | 一种清咽润喉的保健品组合物及其制备方法 | |
CN1903232A (zh) | 一种辣木粉营养品及其制备方法 | |
CN109287828A (zh) | 一种番茄酵母压片糖果及其制备工艺 | |
KR20120138079A (ko) | 닭 사료 조성물 및 이의 제조방법 | |
KR101272093B1 (ko) | 린테우스 상황버섯이 함유된 식용 달팽이 사료 및 그 사료를 이용한 식용 달팽이 사육방법 | |
CN105766710A (zh) | 一种甲鱼白底板病的防治方法 | |
CN105878397A (zh) | 一种调节牛羊运输应激组合物 | |
CN105961837A (zh) | 一种黑鱼饲料添加剂 | |
KR20170142756A (ko) | 굼벵이를 포함하는 간 및 혈액순환 개선용 조성물 및 그 제조방법 | |
KR101324238B1 (ko) | 기능성 사료 및 이의 제조방법 | |
CN106577480A (zh) | 一种提高黄牛抗病力的养殖方法 | |
KR100838113B1 (ko) | 식용금분이 함유된 상황버섯 재배방법 및 그 상황버섯 | |
Khan et al. | A Review-Benefits of Panchgavya therapy (Cowpathy) for health of humans | |
CN105851185A (zh) | 一种具有抗疲劳功效的饼干及其制备方法 | |
CN1303897C (zh) | 降低禽蛋胆固醇和提高生产性能的中药添加剂及制备方法 | |
JP2002209553A (ja) | 制癌性健康食品及び健康食品添加剤 | |
CN101491542A (zh) | 一种具有防癌抗癌作用的富硒蟾衣超微粉 | |
KR20110091959A (ko) | 암의 치료 개선효과를 갖는 무수 유산균발효 건강기능식품 조성물 및 그의 제조방법 | |
CN109042406A (zh) | 一种鳗鱼的养殖方法 | |
KR20190020927A (ko) | 건강보조식품용 환 및 제조방법 | |
Totawar | Critical review of the utilization of Panchagavya in the form of Nutraceuticals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20120913 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20120913 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20121120 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20130524 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130531 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20130603 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20170409 |